Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
30 Nov 2022
Historique:
pubmed: 28 10 2022
medline: 28 10 2022
entrez: 27 10 2022
Statut: epublish

Résumé

We and others have previously shown that the SARS-CoV-2 accessory protein ORF6 is a powerful antagonist of the interferon (IFN) signaling pathway by directly interacting with Nup98-Rae1 at the nuclear pore complex (NPC) and disrupting bidirectional nucleo-cytoplasmic trafficking. In this study, we further assessed the role of ORF6 during infection using recombinant SARS-CoV-2 viruses carrying either a deletion or a well characterized M58R loss-of-function mutation in ORF6. We show that ORF6 plays a key role in the antagonism of IFN signaling and in viral pathogenesis by interfering with karyopherin(importin)-mediated nuclear import during SARS-CoV-2 infection both SARS-CoV-2 ORF6 subverts bidirectional nucleo-cytoplasmic trafficking to inhibit host gene expression and contribute to viral pathogenesis.

Identifiants

pubmed: 36299428
doi: 10.1101/2022.10.18.512708
pmc: PMC9603824
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : U54 CA260560
Pays : United States

Commentaires et corrections

Type : UpdateIn

Auteurs

Classifications MeSH